Navigation Links
New Treatment Eyed for Ewing's Sarcoma

Figitumumab fights tumors and appears to be well-tolerated, researchers say

WEDNESDAY, Dec. 23 (HealthDay News) -- Preliminary research suggests that the anticancer drug figitumumab might be an effective treatment for Ewing's sarcoma, a cancer that affects the areas in and near the bone, mainly in teenage boys.

The drug must undergo two more phases of testing, however, according to a report published in the Dec. 23 online edition of The Lancet Oncology.

In the first phase of research, scientists looked at 29 patients with advanced sarcomas who received the drug between 2006 and 2008. The researchers wanted to assess its safety and ability to be tolerated.

Patients did experience some side effects, such as deep venous thrombosis, back pain and vomiting. Some of the patients appeared to respond well to the drug, the study authors noted.

"Figitumumab is well-tolerated and has antitumor activity in Ewing's sarcoma, warranting further investigation in this disease," the researchers wrote. "Our results show that figitumumab can be safe for both adult and pediatric sarcoma patients, and has single-agent antitumor activity in different sarcoma subtypes, including Ewing's sarcoma."

In a commentary accompanying the study, doctors wrote that "five-drug chemotherapy is routine in the treatment of Ewing's sarcoma, therefore improvement in outcome for these patients will likely require demonstration of the feasibility of combining the antibody with standard chemotherapy."

More information

The U.S. National Library of Medicine has more on Ewing's sarcoma.

-- Randy Dotinga

SOURCE: The Lancet Oncology, news release, Dec. 23, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Modernizing the treatment of sexual dysfunction in men
2. Autism Treatment Crisis: Insufficient Number of Providers to Meet Alarming Increase in Need
3. New insights into mushroom-derived drug promising for cancer treatment
4. Protein link may be key to new treatment for aggressive brain tumor
5. Michael J. Fox Foundation Awards $1 Million for Critical Step Toward Development of Dyskinesia Treatments
6. Diabetes Insight Could Lead to Better Treatments
7. IBS Treatment Center Calls on McCain to Support IBS Research
8. Targeting brain cancer cell metabolism may provide new treatment
9. Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail
10. Free Webinar Series at Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling
11. Early Treatment of Hearing, Vision Helps in Schizophrenia
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: